Physician profile
Paul E Pacheco
NPI 1689872905
$824.36
in general payments reported to CMS, 2019-2025
8 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.75 · 2020: $11.10 · 2021: $63.39 · 2022: $244 · 2023: $258 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $362.40 | 2022-2025 | Divergence-L Anterior/Oblique Lumbar Fusion System, Signia |
| Stryker Corporation | $170.03 | 2022 | |
| Boston Scientific Corporation | $132.43 | 2025 | Overstitch Endoscopic Suturing System |
| Intuitive Surgical, INC. | $63.39 | 2021 | |
| Covidien LP | $47.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.78 | 2025 | Gattex |
| Celgene Corporation | $15.48 | 2022 | |
| Pfizer INC. | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pacheco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.